Salicylic acid

Description

No relevant information for SPL code 34089-3 is available in the provided text.

Uses and Indications

This drug is indicated for the removal of common and plantar warts. Common warts are characterized by their rough, cauliflower-like surface appearance, while plantar warts are specifically located on the bottom of the foot, presenting tenderness and disrupting the normal footprint pattern.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The drug should be administered as directed by a healthcare professional. Dosage may vary based on the patient's condition and response to treatment. It is essential to follow the prescribed dosage regimen strictly to ensure optimal therapeutic effect. Adjustments to the dosage may be necessary based on clinical response and tolerability.

The drug is to be administered via the specified route as indicated in the prescribing information. The frequency of administration should adhere to the healthcare provider's instructions. Proper technique must be employed for the method of administration to maximize efficacy and minimize complications.

Contraindications

Use is contraindicated in the following situations:

Application on irritated skin or any area that is infected or reddened is prohibited due to the potential for exacerbating the condition. Additionally, the product should not be applied to moles, birthmarks, warts with hair growing from them, or warts located on the face or mucous membranes, as these areas may be sensitive or require specialized care.

Oral ingestion of the product is contraindicated; if swallowed, immediate medical assistance or contact with a Poison Control Center is necessary.

The use of this product is also contraindicated in individuals with diabetes or poor blood circulation, as these conditions may increase the risk of adverse effects.

Warnings and Precautions

For external use only. It is imperative to keep this and all medications out of reach of children. In the event of accidental ingestion, immediate professional assistance should be sought, or a Poison Control Center should be contacted without delay.

Users are advised to discontinue use and consult a healthcare professional if discomfort persists for more than 72 hours. Additionally, if discomfort continues, it is recommended to stop use and seek medical advice. Special caution is warranted for individuals with diabetes or poor blood circulation; these patients should also cease use and consult a doctor.

In cases of ingestion, prompt medical help should be obtained, or a Poison Control Center should be contacted immediately.

Side Effects

Patients using this product should be aware that it is for external use only. It is imperative to keep this and all medications out of reach of children. In the event of accidental ingestion, patients are advised to seek professional assistance or contact a Poison Control Center immediately.

Common adverse reactions may include discomfort at the application site. Patients are instructed to discontinue use and consult a healthcare professional if discomfort persists for more than 72 hours. Additionally, individuals with diabetes or poor blood circulation should seek medical advice before using this product.

In summary, patients should monitor for any adverse reactions and take appropriate action if necessary, particularly in cases of prolonged discomfort or if the product is ingested.

Drug Interactions

No specific drug interactions have been identified in the available data. Additionally, there are no reported interactions between the drug and laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on the current information.

Packaging & NDC

Below are the non-prescription pack sizes of Wart Remover Patch. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be closely monitored when using this product. It is essential to keep this and all medications out of reach of children to prevent accidental ingestion. In the event of accidental ingestion, immediate professional assistance should be sought, or a Poison Control Center should be contacted.

If discomfort persists for more than 72 hours, the use of this product should be discontinued, and a healthcare provider should be consulted. Parents and caregivers are advised to stop use and seek medical advice if discomfort continues.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

The product has not been evaluated for safety in pregnant women. Use during pregnancy is not recommended due to potential risks to the fetus. There may be risks associated with the use of salicylic acid during pregnancy; therefore, it is essential for healthcare providers to be consulted before use. No specific dosage modifications are provided for pregnant individuals; however, caution is advised.

Lactation

The safety of this product during lactation has not been established. There is a potential for excretion in breast milk; therefore, caution should be exercised when administering this product to nursing mothers.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of accidental ingestion, it is imperative to seek professional assistance or contact a Poison Control Center immediately. Prompt action is crucial to mitigate potential risks associated with overdosage.

If the substance is swallowed, healthcare professionals should be contacted without delay. Engaging with a Poison Control Center can provide essential guidance on the appropriate management of the situation. It is important for healthcare providers to be prepared to assess the patient's condition and implement necessary interventions based on the severity of the overdosage and the specific substance involved.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's safety profile in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion or misuse.

Patients should be informed that this product should not be applied to irritated skin or any area that is infected or reddened. Additionally, it is important to avoid using the product on moles, birthmarks, warts with hair growing from them, or warts located on the face or mucous membranes.

Healthcare providers should instruct patients to stop using the product and seek medical advice if discomfort persists. Patients with diabetes or poor blood circulation should be particularly cautious and consult a healthcare professional before use. In the event of accidental ingestion, patients should be advised to seek medical help or contact a Poison Control Center immediately.

Storage and Handling

The product is supplied in a configuration that ensures optimal handling and storage. It should be stored at room temperature, specifically in a cool, dry place to maintain its integrity. It is essential to protect the product from light exposure to prevent degradation.

To ensure safety, the product must be kept out of reach of children. Additionally, it is important to discard the product after opening to avoid any potential risks associated with prolonged exposure to air or contaminants.

Additional Clinical Information

The product is administered topically, with specific directions for safe use. Patients should wash the affected area and dry it thoroughly before applying the tag patch. The patch should be removed after 24 hours, and the procedure can be repeated every 24 hours for up to 14 days for tag and wart removal, or up to 12 weeks for warts, until the condition resolves. A hot compress may be applied to the wart in warm water for 5 minutes to aid in removal.

Clinicians should counsel patients to discontinue use and consult a doctor if discomfort persists for more than 72 hours, or if they have diabetes or poor blood circulation. It is also important to keep the product out of reach of children, and to seek medical assistance or contact a Poison Control Center immediately if swallowed.

Drug Information (PDF)

This file contains official product information for Wart Remover Patch, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)